Physician

Vinay Bhushan Sanghi, MD

According to 2025 Medicare claims, Vinay Sanghi, MD (NPI: 1114911203) practices cardiology in the Sierra Vista-Douglas, AZ market, with the plurality of this provider's patient population coming from Cochise, AZ. This provider's primary affiliated billing organization is HEART AND VASCULAR ASSOCIATES LLC (NPI: 1124512710; TIN: 825120744) and primary practice location at 85635-4783. Sanghi is affiliated with the ABC Network (ACO ID: A5554), participating under the MSSP model.

Sanghi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,556 traditional Medicare patients, billed 11,123 HCPCS/CPT codes, and received $967,373 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,932 prescription claims across 933 beneficiaries totaling $941,671 in drug costs, led by Jardiance (Empagliflozin). 2019 DME data shows 13 claims. Open Payments data shows 5 records totaling $135. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $72,591 to $967,373. Similarly, Part D prescription costs have moved sharply higher in recent years, from $14,340 to $941,671. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	389	1,026	$72,591
2018	706	2,143	$207,013
2019	1,291	5,266	$595,492
2020	1,057	3,552	$481,965
2021	1,039	3,729	$455,982
2022	1,138	5,891	$706,898
2023	1,532	8,708	$914,269
2024	1,556	11,123	$967,373

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	62	229	$14,340
2018	143	909	$71,075
2019	322	1,768	$108,423
2020	438	2,366	$197,067
2021	443	2,106	$210,693
2022	509	2,202	$267,401
2023	748	3,816	$641,790
2024	933	4,932	$941,671

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	17	$34,299
2019	N/R	13	$28,983
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	784	845	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	898	1,203	$92
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	447	452	$16
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	778	909	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,056	1,193	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	281	18,358	$319,939
Eliquis	Apixaban	258	15,769	$289,445
Xarelto	Rivaroxaban	77	5,370	$95,661
Entresto	Sacubitril/Valsartan	89	5,330	$90,429
Repatha Syringe	Evolocumab	37	2,798	$46,705

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$135	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vinay Bhushan Sanghi, MD?

Tedicare shows public-source Medicare data for Vinay Bhushan Sanghi, MD (NPI 1114911203), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinay Bhushan Sanghi, MD have ACO affiliation data?

Vinay Bhushan Sanghi, MD is shown with ACO affiliation data for ABC Network (MSSP, ACO ID A5554).

What billing organization is linked to Vinay Bhushan Sanghi, MD?

Vinay Bhushan Sanghi, MD is linked to HEART AND VASCULAR ASSOCIATES LLC (billing NPI 1124512710) in the available physician profile data.

Does Vinay Bhushan Sanghi, MD have Open Payments data?

Vinay Bhushan Sanghi, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.